Press release
Oncology Biosimilars Market Growth 2025 | Market Highlights, Top Companies & Emerging Markets
Oncology Biosimilars Market
DataM Intelligence has released its latest report on the "Oncology Biosimilars Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.
In September 2025, Alkem Laboratories introduced a biosimilar product in India for breast cancer treatment. The company launched Pertuza injection 420mg/14mL, a pertuzumab biosimilar designed to treat HER2-positive breast cancer. Alkem's Pertuza is an affordable, domestically developed and manufactured biosimilar offering a cost-effective alternative to pertuzumab.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/oncology-biosimilars-market?kb
United States: Recent Industry Developments - Oncology Biosimilars
✅ October 2025: The FDA approved multiple trastuzumab and bevacizumab biosimilars expanding cancer care access.
✅ September 2025: Market share for oncology biosimilars rose sharply across leading hospital networks.
✅ August 2025: Manufacturers pursued co-marketing deals to strengthen distribution and pricing strategies.
Japan: Recent Industry Developments
✅ October 2025: Japanese firms launched locally produced oncology biosimilars under expedited regulatory pathways.
✅ September 2025: Health insurance programs expanded coverage for cost-effective biosimilar options.
✅ August 2025: Hospital systems implemented education campaigns to increase clinician adoption.
Key Player:
Celltrion USA, Inc., Amgen Inc., Pfizer Inc., Biocon Biologics Limited, Teva Pharmaceuticals USA, Inc., Organon group of companies, Accord BioPharma, and Sandoz Inc
Forecast Projection:
The global Oncology Biosimilars market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.
Market Intelligence Research Process:
The Oncology Biosimilars Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=oncology-biosimilars-market?kb
Key Segments:
By Product Type: (Monoclonal Antibodies (mAbs), Recombinant Proteins, Granulocyte Colony-Stimulating Factor (G-CSF), Erythropoiesis-Stimulating Agents, and Others)
By Indication: (Breast Cancer, Lung Cancer, Colorectal Cancer,
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/oncology-biosimilars-market?kb
Key Market Highlights (Rephrased):
North America holds the leading position in the oncology biosimilars market, accounting for the largest revenue share of 44.57% in 2024.
The Asia Pacific region is the fastest-growing market, projected to achieve a CAGR of 18.7% over the forecast period.
By product type, the monoclonal antibodies (mAbs) segment dominated the market with a 40.32% revenue share in 2024.
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/oncology-biosimilars-market?kb
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Biosimilars Market Growth 2025 | Market Highlights, Top Companies & Emerging Markets here
News-ID: 4257330 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Smart Factory Market to Reach US$ 290.6 Billion by 2033 at 12.6% CAGR; North Ame …
The Global Smart Factory Market reached US$ 112.4 billion in 2024 and is expected to reach US$ 290.6 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033. Market growth is driven by increasing adoption of Industry 4.0 practices, rising demand for automation and operational efficiency, and growing integration of digital technologies across manufacturing industries.
Smart factories leverage advanced technologies such as the Industrial Internet of Things…
Radiofrequency Ablation Devices Market to Reach US$ 13.54 Billion by 2033 at 10. …
The Global Radiofrequency Ablation Devices Market reached US$ 5.63 billion in 2024 and is expected to reach US$ 13.54 billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of chronic pain conditions and cancer, increasing preference for minimally invasive procedures, and advancements in ablation technologies.
Radiofrequency ablation devices are used to treat tumors, cardiac arrhythmias, and chronic pain…
Mobile Threat Defense (MTD) Market to Reach US$ 10.5 Billion by 2030, Growing at …
According to DataM Intelligence, the global Mobile Threat Defense (MTD) market reached US$ 2.2 billion in 2022 and is expected to reach US$ 10.5 billion by 2030, growing at a CAGR of 22.0% during the forecast period 2024-2031. This growth is propelled by the rapid surge in mobile malware, phishing, and ransomware attacks targeting enterprises, increasing adoption of BYOD and remote work policies, strong demand for cloud-based MTD solutions, rising…
Digital Identity Solutions Market to Reach US$ 189.92 Billion by 2033 at 20.45% …
The Global Digital Identity Solutions Market reached US$ 35.50 billion in 2023 and increased to US$ 42.45 billion in 2024, and is expected to reach US$ 189.92 billion by 2033, growing at a CAGR of 20.45% during the forecast period 2025-2033. Market growth is driven by the rising need for secure identity verification, increasing digitalization across industries, and growing concerns over identity fraud and data security.
Digital identity solutions enable the…
More Releases for Oncology
Precision Oncology Market Top Companies Study - Laboratory Corporation of Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031"
The global Precision Oncology market is estimated to reach over USD…
Veterinary Oncology Market Report 2024 - Veterinary Oncology Market Size, Share …
"The Business Research Company recently released a comprehensive report on the Global Veterinary Oncology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The veterinary oncology market size…
Hepatocellular Carcinoma Pipeline 2024 | Can-Fite BioPharma, Sinocelltech, AVEO …
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hepatocellular Carcinoma Pipeline…
Oncology Clinical Trials Market: Collaboration and Innovation in Oncology Resear …
Allied Market Research analysts have recently conducted a comprehensive research study titled "Oncology Clinical Trials Market: Global Outlook and Forecast 2023-2030." The report provides detailed information and analysis on key players in the market, including PAREXEL International, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, Novartis, Merck, Bristol Myers Squibb company, and F. Hoffmann-La Roche. The study offers an in-depth analysis that encompasses clear market definitions, classifications, manufacturing processes, cost…
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
Oncology Market Size to Hit $447.3 Billion by 2028 | Oncology Industry Forecast …
Market Overview:
According to our experience research team, Oncology Market was valued at USD 283.5 Billion in 2021, and the global Oncology industry is projected to reach a value of USD 447.3 Billion by 2028, at a CAGR of 7.9% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy & Power, Agriculture,…
